Categories Earnings, Earnings Call Transcripts, Technology
Wall Street’s favorite cloud firm Salesforce to report Q1 earnings on June 4
Salesforce (NYSE: CRM) is arguably Wall Street’s favorite cloud company; the stock has seen a staggering 87% growth so far this year. The company is now slated to report first-quarter 2020 earnings results next week and investors are looking at an extended bull run.
The results are scheduled to be announced after the regular trading hours on Tuesday, June 4. Analysts have projected Q1 earnings of 61 cents per share on revenues of $3.68 billion, up 22% year-over-year.
The street consensus falls within the top end of the forecast made by the management during the last earnings announcement. The San Francisco, California-based company had said that it expects to see quarterly revenues hitting $3.67-3.68 billion, generating GAAP EPS of $0.10-0.11 and non-GAAP EPS of $0.60-0.61.
Salesforce has a good history of beating market estimates; however, the high expectations maintained by investors could backfire if it fails to outperform. During the last-reported quarter, despite beating the estimates on both the top and bottom line, shares fell as investors were unimpressed with the Q1 outlook.
Since there seems to be no slowing down of demand for its customer-relationship-management software, expect to see increased client base this quarter. Regular product launches and robust expansion in the international markets will continue to impact top line growth for the company. The acquisition of Mulesoft last year should also provide some fillip to the top line in Q1.
During the earnings conference calls, you may expect to hear more about the company’s expansion strategy, which are powered by partnerships with leading tech firms including Alphabet (NASDAQ: GOOGL) and Amazon (NASDAQ: AMZN).
Even though some market observers feel the stock is overpriced, it continues to have a 12-month average price target that suggests otherwise. The average price target on the stock is $183.50, suggesting an 18% upside from the last close.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
